Skip to main content
TipRanks
Go Ultimate75% OFF

Susan Bayh Insider Profile

4 Followers

Susan Bayh, Director at Emmis Communications, holds 36.19K shares in Emmis Communications (Ticker: EMMS), holds ― shares in Northwest Biotherapeutics (Ticker: NWBO), holds 115.76K shares in Dendreon Corp (Ticker: DNDNQ).

Susan Bayh's Trading History

EMMS
Emmis Communications
Jul 09, 2019DirectorUninformative Buy1.66K$56.09K
DNDNQ
Dendreon Corp
Jan 07, 2014―Uninformative Buy――
ELV
Elevance Health
May 23, 2012DirectorInformative Sell196.17K$0.00
CRIS
Curis
Dec 27, 2011DirectorUninformative Sell133.67K$10.88K
NVAX
Novavax
―Director―$0.00
DYAX
Dyax Corp
―――$0.00
NWBO
Northwest Biotherapeutics
―Director――

You May Also Like

Susan Bayh insider profile FAQ

What is the percentage of profitable transactions made by Susan Bayh?
The percentage of profitable transactions made by Susan Bayh is 56%.
What is the average return per transaction made by Susan Bayh?
The average return per transaction made by Susan Bayh is 4.80%.
What stocks does Susan Bayh hold?
Susan Bayh holds: EMMS, NWBO, CRIS, DNDNQ, DYAX, NVAX, ELV stocks.
What was Susan Bayh’s latest transaction?
Susan Bayh’s latest transaction was an Uninformative Buy of $1.66K.
What was Susan Bayh's most profitable transaction?
Susan Bayh’s most profitable transaction was an Informative Sell of EMMS stock on July 14, 2010. The return on the trade was 52.50%.
What is Susan Bayh's role in Emmis Communications?
Susan Bayh's role in Emmis Communications is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.